Clinical Trial Update: Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating Kappa-PET imaging and naltrexone effects on alcohol drinking behavior has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol-related Disorders

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Yale University | Conditions: Alcohol Drinking | Phase 1 | Status: COMPLETED | Results posted: 2022-08-10